These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 39390582

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Systematic perturbations of SETD2, NSD1, NSD2, NSD3 and ASH1L reveals their distinct contributions to H3K36 methylation.
    Shipman GA, Padilla R, Horth C, Hu B, Bareke E, Vitorino FN, Gongora JM, Garcia BA, Lu C, Majewski J.
    bioRxiv; 2023 Oct 18. PubMed ID: 37905045
    [Abstract] [Full Text] [Related]

  • 3. Structural and functional specificity of H3K36 methylation.
    Lam UTF, Tan BKY, Poh JJX, Chen ES.
    Epigenetics Chromatin; 2022 May 18; 15(1):17. PubMed ID: 35581654
    [Abstract] [Full Text] [Related]

  • 4. In vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1 and NSD3/WHSC1L.
    Morishita M, Mevius D, di Luccio E.
    BMC Struct Biol; 2014 Dec 12; 14():25. PubMed ID: 25494638
    [Abstract] [Full Text] [Related]

  • 5. Molecular basis of nucleosomal H3K36 methylation by NSD methyltransferases.
    Li W, Tian W, Yuan G, Deng P, Sengupta D, Cheng Z, Cao Y, Ren J, Qin Y, Zhou Y, Jia Y, Gozani O, Patel DJ, Wang Z.
    Nature; 2021 Feb 12; 590(7846):498-503. PubMed ID: 33361816
    [Abstract] [Full Text] [Related]

  • 6. Histone H2A ubiquitination inhibits the enzymatic activity of H3 lysine 36 methyltransferases.
    Yuan G, Ma B, Yuan W, Zhang Z, Chen P, Ding X, Feng L, Shen X, Chen S, Li G, Zhu B.
    J Biol Chem; 2013 Oct 25; 288(43):30832-42. PubMed ID: 24019522
    [Abstract] [Full Text] [Related]

  • 7. Kinetic characterization of human histone H3 lysine 36 methyltransferases, ASH1L and SETD2.
    Eram MS, Kuznetsova E, Li F, Lima-Fernandes E, Kennedy S, Chau I, Arrowsmith CH, Schapira M, Vedadi M.
    Biochim Biophys Acta; 2015 Sep 25; 1850(9):1842-8. PubMed ID: 26002201
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. NSD1-deposited H3K36me2 directs de novo methylation in the mouse male germline and counteracts Polycomb-associated silencing.
    Shirane K, Miura F, Ito T, Lorincz MC.
    Nat Genet; 2020 Oct 25; 52(10):1088-1098. PubMed ID: 32929285
    [Abstract] [Full Text] [Related]

  • 10. The H3.3 G34W oncohistone mutation increases K36 methylation by the protein lysine methyltransferase NSD1.
    Bröhm A, Schoch T, Grünberger D, Khella MS, Schuhmacher MK, Weirich S, Jeltsch A.
    Biochimie; 2022 Jul 25; 198():86-91. PubMed ID: 35341929
    [Abstract] [Full Text] [Related]

  • 11. The histone mark H3K36me2 recruits DNMT3A and shapes the intergenic DNA methylation landscape.
    Weinberg DN, Papillon-Cavanagh S, Chen H, Yue Y, Chen X, Rajagopalan KN, Horth C, McGuire JT, Xu X, Nikbakht H, Lemiesz AE, Marchione DM, Marunde MR, Meiners MJ, Cheek MA, Keogh MC, Bareke E, Djedid A, Harutyunyan AS, Jabado N, Garcia BA, Li H, Allis CD, Majewski J, Lu C.
    Nature; 2019 Sep 25; 573(7773):281-286. PubMed ID: 31485078
    [Abstract] [Full Text] [Related]

  • 12. Expression and prognostic value of NSD1 and SETD2 in pancreatic ductal adenocarcinoma and its precursor lesions.
    Ettel M, Zhao L, Schechter S, Shi J.
    Pathology; 2019 Jun 25; 51(4):392-398. PubMed ID: 31060750
    [Abstract] [Full Text] [Related]

  • 13. Context-Dependent and Locus-Specific Role of H3K36 Methylation in Transcriptional Regulation.
    Lee MK, Park NH, Lee SY, Kim T.
    J Mol Biol; 2025 Jan 01; 437(1):168796. PubMed ID: 39299382
    [Abstract] [Full Text] [Related]

  • 14. The T1150A cancer mutant of the protein lysine dimethyltransferase NSD2 can introduce H3K36 trimethylation.
    Khella MS, Schnee P, Weirich S, Bui T, Bröhm A, Bashtrykov P, Pleiss J, Jeltsch A.
    J Biol Chem; 2023 Jun 01; 299(6):104796. PubMed ID: 37150325
    [Abstract] [Full Text] [Related]

  • 15. Low expression of NSD1, NSD2, and NSD3 define a subset of human papillomavirus-positive oral squamous carcinomas with unfavorable prognosis.
    Gameiro SF, Ghasemi F, Zeng PYF, Mundi N, Howlett CJ, Plantinga P, Barrett JW, Nichols AC, Mymryk JS.
    Infect Agent Cancer; 2021 Feb 15; 16(1):13. PubMed ID: 33588906
    [Abstract] [Full Text] [Related]

  • 16. NSD3, a member of nuclear receptor-binding SET domain family, is a potential prognostic biomarker for pancreatic cancer.
    Xiong Q, Zhou Y, Zhang S, Zhang Y, Xu Y, Yang Y, Zhou C, Zeng Z, Han J, Zhu Q.
    Cancer Med; 2023 May 15; 12(9):10961-10978. PubMed ID: 37062069
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of NSD2 and NSD3 in overgrowth syndromes.
    Douglas J, Coleman K, Tatton-Brown K, Hughes HE, Temple IK, Cole TR, Rahman N, Childhood Overgrowth Collaboration.
    Eur J Hum Genet; 2005 Feb 15; 13(2):150-3. PubMed ID: 15483650
    [Abstract] [Full Text] [Related]

  • 18. The NSD family of protein methyltransferases in human cancer.
    Vougiouklakis T, Hamamoto R, Nakamura Y, Saloura V.
    Epigenomics; 2015 Aug 15; 7(5):863-74. PubMed ID: 25942451
    [Abstract] [Full Text] [Related]

  • 19. NSD1 Inactivation and SETD2 Mutation Drive a Convergence toward Loss of Function of H3K36 Writers in Clear Cell Renal Cell Carcinomas.
    Su X, Zhang J, Mouawad R, Compérat E, Rouprêt M, Allanic F, Parra J, Bitker MO, Thompson EJ, Gowrishankar B, Houldsworth J, Weinstein JN, Tost J, Broom BM, Khayat D, Spano JP, Tannir NM, Malouf GG.
    Cancer Res; 2017 Sep 15; 77(18):4835-4845. PubMed ID: 28754676
    [Abstract] [Full Text] [Related]

  • 20. NSD1 deposits histone H3 lysine 36 dimethylation to pattern non-CG DNA methylation in neurons.
    Hamagami N, Wu DY, Clemens AW, Nettles SA, Li A, Gabel HW.
    Mol Cell; 2023 May 04; 83(9):1412-1428.e7. PubMed ID: 37098340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.